These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 6470141

  • 1. Aggregating platelets contract isolated canine pulmonary arteries by releasing 5-hydroxytryptamine.
    McGoon MD, Vanhoutte PM.
    J Clin Invest; 1984 Sep; 74(3):828-33. PubMed ID: 6470141
    [Abstract] [Full Text] [Related]

  • 2. 5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries.
    Cohen RA, Shepherd JT, Vanhoutte PM.
    Am J Physiol; 1983 Dec; 245(6):H1077-80. PubMed ID: 6660308
    [Abstract] [Full Text] [Related]

  • 3. Cooling augments platelet-induced contraction of peripheral arteries of the dog.
    Lindblad LE, Shepherd JT, Vanhoutte PM.
    Proc Soc Exp Biol Med; 1984 Jun; 176(2):119-22. PubMed ID: 6718355
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Adenine nucleotides, serotonin, and endothelium-dependent relaxations to platelets.
    Houston DS, Shepherd JT, Vanhoutte PM.
    Am J Physiol; 1985 Mar; 248(3 Pt 2):H389-95. PubMed ID: 3156512
    [Abstract] [Full Text] [Related]

  • 6. Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels.
    Lorenz RR, Vanhoutte PM.
    Am J Physiol; 1985 Sep; 249(3 Pt 2):H685-9. PubMed ID: 4037113
    [Abstract] [Full Text] [Related]

  • 7. Role of serotonin, histamine, and thromboxane A2 in platelet-induced contractions of coronary arteries and aortae from rabbits.
    Awano K, Yokoyama M, Fukuzaki H.
    J Cardiovasc Pharmacol; 1989 May; 13(5):781-92. PubMed ID: 2472528
    [Abstract] [Full Text] [Related]

  • 8. Heterogeneity of endothelium-dependent and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries.
    Zellers TM, Shimokawa H, Yunginger J, Vanhoutte PM.
    Circ Res; 1991 May; 68(5):1437-45. PubMed ID: 2019001
    [Abstract] [Full Text] [Related]

  • 9. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA.
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effects of platelet-derived contractile agents on human digital arteries.
    Moulds RF, Iwanov V, Medcalf RL.
    Clin Sci (Lond); 1984 Apr; 66(4):443-51. PubMed ID: 6697664
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of 5-hydroxytryptamine-induced and -amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist.
    de Clerck F, David JL, Janssen PA.
    Agents Actions; 1982 Jul; 12(3):388-97. PubMed ID: 6215842
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets.
    Cohen RA, Shepherd JT, Vanhoutte PM.
    Science; 1983 Jul 15; 221(4607):273-4. PubMed ID: 6574604
    [Abstract] [Full Text] [Related]

  • 15. Different interactions of platelets with arterial and venous coronary bypass vessels.
    Yang ZH, Stulz P, von Segesser L, Bauer E, Turina M, Lüscher TF.
    Lancet; 1991 Apr 20; 337(8747):939-43. PubMed ID: 1678031
    [Abstract] [Full Text] [Related]

  • 16. Release of a neutrophil-derived vasoconstrictor agent which augments platelet-induced contractions of blood vessels in vitro.
    Sessa WC, Mullane KM.
    Br J Pharmacol; 1990 Mar 20; 99(3):553-9. PubMed ID: 2110018
    [Abstract] [Full Text] [Related]

  • 17. Response of isolated cat middle cerebral artery to platelets: effect of endothelium removal.
    López de Pablo AL, Marco EJ, Benito JM, Fraile ML, Sanz ML, Moreno MJ, Conde MV.
    Gen Pharmacol; 1991 Mar 20; 22(2):353-8. PubMed ID: 2055430
    [Abstract] [Full Text] [Related]

  • 18. Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.
    Van Nueten JM, Janssen PA, Van Beek J, Xhonneux R, Verbeuren TJ, Vanhoutte PM.
    J Pharmacol Exp Ther; 1981 Jul 20; 218(1):217-30. PubMed ID: 6113280
    [Abstract] [Full Text] [Related]

  • 19. Platelet-mediated vascular contractions: inhibition of the serotonergic component by ketanserin.
    De Clerck F, Van Nueten JM.
    Thromb Res; 1982 Sep 15; 27(6):713-27. PubMed ID: 6817452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.